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Vaccine safety monitoring is an essential component of immunisation programs 
that aims to provide reassurance to the community and health care workers of the 
safety of vaccines and to enable potential safety signal detection. Pre-marketing 
vaccine safety studies are generally conducted on healthy participants; post-
marketing surveillance should include groups who are underrepresented in vaccine 
clinical trials. This may include younger and older age-groups, people with 
underlying health conditions and minority groups. Participant-centred active 
Adverse Event Following Immunisation (AEFI) surveillance is increasingly 
recognised as an efficient way of contacting vaccine recipients and directly 
gathering data on their near real-time vaccine experience (Cashman et al., 2017; 
Pillsbury et al., 2017). 
In Australia, there have been substantial and long-standing gaps in health 
outcomes between Aboriginal and Torres Strait Islander People (hereafter 
respectfully called Aboriginal People) and the rest of the population (Holland, 
2018). This is well described for vaccine-preventable diseases (Naidu et al, 2013). 
During the 2009 influenza pandemic, Aboriginal people, particularly those in 
regional and remote communities, were found to experience higher morbidity and 
mortality than non-Aboriginal people in Australia (Kelly, Mercer and Cheng, 
2009). The primary barrier for Aboriginal people receiving the influenza vaccine is 
concern about the potential side effects (Wolstenholme, Duffy and Smith, 2017). 
Thus, concerns about safety, which might hamper vaccine uptake, should be 
actively allayed.  
It is essential to ensure Aboriginal involvement in active AEFI surveillance, 
so that trust can be built. Supporting Aboriginal involvement in AEFI surveillance 
is an important component in building trust in vaccination. The advent of improved 
personal communication and access to smartphones and email has enabled active 
engagement and direct involvement with community members before (such as pre-
call systems) and after immunisation. Immunised individuals or their carers are 
actively canvassed for their own experience following immunisation, which has 
facilitated adverse event data collection but also has the potential to make vaccine 
safety more transparent for consumers. To enhance AEFI surveillance, we 
developed an active web-based participant-centred vaccine safety monitoring 
system called Vaxtracker, which is an active member of the AusVaxSafety 
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consortium. Vaxtracker aims to detect signals indicating a possible vaccine safety 
issue by sending a SMS (short message service) and/or email three days after 
immunisation. Clicking or tapping on the embedded link allows completion of an 
online survey.   
In 2015, Aboriginal children aged six months to less than five years of age 
became eligible for funded seasonal influenza vaccine under the Australian 
National Immunisation Program (NIP) and in 2016 a diphtheria, tetanus and 
acellular pertussis (DTPa) booster vaccine was introduced for all 18-month-old 
children. Both changes were accompanied by enhanced vaccine safety surveillance 
through the national AusVaxSafety consortium, in which Vaxtracker participates. 
These changes to the NIP provided the opportunity to better understand 
participation of Aboriginal people in the active AEFI surveillance and explore 
factors that may impact on their participation. 
Methods  
At the time of immunisation with either the influenza or DTPa vaccine, children’s 
parents or carers were asked by practice or clinic health staff if they would like to 
participate in the Vaxtracker program. Links to the online survey were sent via the 
contact method chosen by the parent or carer (email and/or SMS). Written 
information describing the Vaxtracker program was available for parents. A 
welcome message was sent one day after the immunisation and the link to the 
survey followed three days after the immunisation. If there was no response to the 
survey after three days, then two automated reminders were sent three days apart 
on days six and nine post immunisation. Twenty-three general practices, four 
Aboriginal Medical Services (AMS) and one Community Health Centre in the 
Hunter New England Local Health District, New South Wales, Australia, enrolled 
parents and carers of vaccinated children into the study.  
To explore potential barriers to participation in automated active AEFI 
surveillance, Aboriginal Immunisation Officers attempted to interview all parents 
or carers of children who did not respond to the Vaxtracker surveys. Families whose 
children had a vaccination date from 5 April to 24 October 2016 where included in 
this study.  
Two questionnaires were used during the follow-up interviews by the 
Aboriginal Immunisation Officers. Firstly, the Vaxtracker AEFI questionnaire was 
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used only with Aboriginal parents who did not respond to the influenza vaccine 
online survey. This AEFI survey was modified to ensure the language was more 
suitable for a person to person telephone interview. The demographic and AEFI 
data gathered telephonically were manually entered by the study interviewer into 
the Vaxtracker web-based program to add to the data already collected from the 
web-based influenza vaccine questionnaire from the online parental responders. 
The second person-to-person telephone questionnaire (Evaluation Questionnaire) 
explored possible barriers to accessing Vaxtracker for Aboriginal and non-
Aboriginal participants for both the influenza and DTPa vaccines. These responses 
were collated separately in an MS Excel spreadsheet. 
Training was provided for two Aboriginal Immunisation Officers on 
interviewing people using the two questionnaires, data entry on the Vaxtracker and 
MS Excel, and the referral process to a public health clinician for appropriate follow 
up if an adverse event was reported.  
Aboriginal Immunisation Officers attempted to contact parents and carers 
who had not completed the online automated survey ten days after their vaccination 
date with three phone call attempts and/or three email attempts made for each 
family. These contact attempts were made over a one-week period, at different 
times of the day. Messages were left if there was a voice mail service available. 
Once 28 days had lapsed since vaccination, no further contact was attempted. Phone 
calls were made from an ‘unblocked’ land line number so that the phone number 
was visible to phone call recipient. The protocol used for this study is available 
from the authors. 
Data collected as part of the study was analysed in Stata 15 Statistical 
Package. Basic descriptive analysis was conducted on each vaccine program 
individually. 
In Australia, health professionals are required to report adverse event 
following immunisation to the Therapeutic Goods Administration (TGA) and State 
and Territory Health Departments. The follow-up of people who did not respond to 
the automated survey was considered a quality improvement activity to assess the 
impact of AEFI surveillance and was authorised as a non-research activity by the 
Hunter New England Human Research Ethics Committee Authorisation Number 
AU201506-3.  
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There was a differential response rate for both vaccines between Aboriginal and 
non-Aboriginal enrolees, with statistically significantly lower responses from 
Aboriginal parents for both vaccines (Table 1). The methods of response were 
similar for Aboriginal and non-Aboriginal families using the link to the online 
survey from both email and SMS (Table 1).  
For Aboriginal children, those enrolled through a general (family) practice 
were more likely to respond than those enrolled through an Aboriginal Medical 
Service. There was no significant difference in the age distribution of the children 
from six months to under five years for families who responded.   
Aboriginal immunisation officers were able to contact the non-responding 
parents or carers of 25 of the 53 Aboriginal children in 50 Aboriginal families 
(47.2%) and 31 of the 122 non-Aboriginal children (25.4%) in 105 non-Aboriginal 
families. The parents or carers of 119 children (Aboriginal children n=28 in 26 
families, non-Aboriginal children n=91 in 77 families) were either unable to be 
contacted or 28 days had elapsed since the vaccination. The most common reason 
for not being contacted was that 28 days had passed since the vaccination 
(Aboriginal n=13/28, non-Aboriginal n=75/91). Other reasons included that the 
phone number was incorrect (Aboriginal n=7, non-Aboriginal n=3) and lost to 
follow-up by having three unanswered calls (Aboriginal n=6, non-Aboriginal n=4).  
One of the 12 interviews of parent/carers who did not respond to the online 
survey after influenza immunisation of an Aboriginal child reported a localised 
reaction (8.3%) during this follow-up study. This rate was low compared to 22% 
(36/167) of people responding to the automated online influenza vaccine AEFI 
survey. 
During the follow-up telephone interviews regarding reasons for non-
response, the interviewers allocated responses into categories. The most common 
reason provided by both Aboriginal and non-Aboriginal parent/carers for not 
completing the survey was being “too busy” (50.0% and 75% respectively) (Table 
2). Technological issues such as problems with the mobile telephone or the network 
were more common among Aboriginal non-responders 33.3% compared to 7.1%. 
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Table 1: Vaxtracker AEFI survey responses by Parents and Carers of 
Aboriginal and non-Indigenous children, for Influenza and DTPa 
vaccine in 2016 
 Influenza DTPa 
 No. (%) P value4 No. (%) P value4 
No. of parents/carers agreeing to 
participate in Vaxtracker: 
193  568  
• Representing Aboriginal children 
55 (28.5)  78 (13.7)  







No of surveys completed (by 
















Survey completion by 
Aboriginality1 
    













Preferred contact method selected by participants 
• Parents/carers: 
Aboriginal children 




2 (3.6)  0 (0.0)  
 SMS only 32 (58.2)  45 (57.7)  
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7 (5.1)  27 (5.5)  
 SMS only 48 (34.1)  67 (13.7)  
Response rate by method 1     
• Parents/carers: 
Aboriginal children 



















Response rate by clinic type: Aboriginal children1 















Response rate by clinic type: non-Indigenous children1 












Notes: 1. Surveys completed by parents only, does not include surveys completed by Aboriginal 
Immunisation Officers  
 2. DTPa Vaxtracker is an ongoing program. Children with a vaccination date from 5/4-
24/10/2016 were included in this study 
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Table 2:  Reasons provided for not responding to the Vaxtracker AEFI surveys 




children  (N=24) 
Parents/carers of 
non-Aboriginal 







 n (%) n (%)   












































Multiple responses per participant possible 
1. Includes all user and device technical issues including no credit 
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There are many gaps in health outcomes between Aboriginal people and the rest of 
the Australian population, which we also found in this study of the early use of 
participant-centred AEFI surveillance. There was a differential response rate for 
both vaccines’ online AEFI surveys between Aboriginal and non-Aboriginal 
enrolees. 
In interpreting these findings, it is important that the following limitations 
are considered. The sample size was small, and the interviewers were not blinded. 
Responses to telephone surveys may have provided relatively superficial reasons 
rather than when these are explored in-depth in person and some people may have 
found the telephone survey confronting. As there was naturally a delay before 
seeking reasons for not completing the survey, potentially up to 28 days, recall bias 
may have been a factor. The study had no additional resourcing and delays in 
making the telephone calls excluded a number of participants, in order to limit the 
potential for recall bias.  
We found that parents/carers were more likely to respond if they provided 
both an email address and mobile phone number to the vaccination clinic. As 
parents/carers of non-Aboriginal children were more likely to provide both contact 
options when compared to the parents/carers of Aboriginal children, they would 
have received twice the number of survey prompts and reminder messages, which 
may have increased the opportunity of responding to a message (Australian 
Ministers’ Advisory Council, 2017). When Aboriginal people nominated both SMS 
and email, they were more likely to respond from the link sent by email (50%). 
Both technologies are worth exploring to enable Aboriginal people to access health 
information services, however, their preference should be monitored over time, as 
this may be influenced by cost and availability of emerging technologies.  
Response rates of the parents/carers of Aboriginal children who received 
their vaccination at an Aboriginal Medical Service (AMS) were lower when 
compared to those visiting a General Practice. We were unable to identify why this 
difference exists. The Aboriginal and Torres Strait Islander Health Performance 
Framework 2017 Report (Australian Ministers’ Advisory Council, 2017) found that 
most Aboriginal and Torres Strait Islander people went to a doctor if they had a 
health problem (54%), followed by Aboriginal Medical Services (AMS) (17%), 
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with use of AMS and community clinics increasing from 13% in major cities to 
66% in very remote areas. Aboriginal participants in this AEFI surveillance 
followed a similar pattern with more outer regional and remote area participants 
serviced by AMSs. Over 50% of Aboriginal people live in major cities or regional 
centres (Marles, Frame and Royce, 2012). Our study area in the HNELHD in NSW 
covers the city of Newcastle and regional areas of NSW but not very remote areas. 
The relative geographic isolation of some Aboriginal families may explain the more 
frequent mention of technical issues impacting on their ability to respond to online 
surveys. Although general (family) practice may not have a high proportion of 
Aboriginal clients it is an important place of care where active surveillance is 
potentially useful and informative for Aboriginal people (Australian Ministers’ 
Advisory Council, 2017). Further strategies may be required to reach and canvas 
Aboriginal people living in remote and very remote areas to ensure inclusion in 
appropriately designed AEFI surveillance.   
Although telephone credit was mentioned as a barrier by four respondents 
(3 Aboriginal and 1 non-Aboriginal) it appears to be less of a barrier than was 
anticipated following discussions with health professionals prior to the study. 
Aboriginal people did report technology difficulties more than non-Aboriginal 
people (41.7% cf 10.7%, p value 0.010), however, care should be taken when 
interpreting these data, as numbers of participants are small. However, in a 2015 
survey of Aboriginal women about immunisation during pregnancy in Western 
Australia, over half of the 400 women sampled had a phone number that was 
incorrect or not functional (Lotter et al., 2018). Mobile phones are an increasingly 
efficient means of involving people in health and health data collection, but care is 
required to ensure Aboriginal people are not excluded and are able to contribute 
their experiences, in this case, vaccine adverse events. In 2017, the Aboriginal and 
Torres Strait Islander participation in the national AusVaxSafety database was 
2.0%, whereas Aboriginal and Torres Strait Islander people comprise 3.3% of the 
Australian population (Pillsbury et al., 2018).  
Young Aboriginal people are rapid adopters of new technologies, including 
smartphones, which can facilitate participation in culturally important activities, 
such family and community connectivity, but factors such as socioeconomic status 
and remoteness may impact on uptake. A review of social media use by young 
Aboriginal people concluded that future use could bridge health and education gaps 
(Rice et al., 2016). The Menzies School of Health Research has successfully 
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demonstrated the use of an app to prevent overconsumption of sugary drinks in 
remote Communities in the Northern Territory (Tonkin et al., 2017). These case 
studies suggest that use of new technology alone does not necessarily exclude 
Aboriginal people. We recognise that deeper understanding is required on how to 
best engage Aboriginal families in active AEFI surveillance and a qualitative study 
using a “yarning circle” methodology may be worthwhile to ensure that current 
inequality in health service provision is not perpetuated (Dunleavy, 2013).   
Conclusion 
There is growing recognition that active automated participant-based surveillance 
is an important contributor to assess the post-marketing safety of vaccines 
(Pillsbury et al., 2017). This method likely improves vaccine safety signal detection 
and potentially contributes to better confidence in vaccines (Cashman et al., 2017; 
Crawford et al., 2014). The response rates to the active AEFI surveillance in this 
study were generally good in both non-Aboriginal and Aboriginal families, but 
lower in the latter. Involving Aboriginal people in active AEFI surveillance is 
critical to the surveillance of safety as new vaccines, for example pandemic 
vaccines, are introduced in higher risk subpopulations, including First Nations 
Peoples. Vaccine safety is a concern for some Aboriginal people (Wolstenholme, 
Duffy and Smith, 2017) so all the more important that Aboriginal people have the 
opportunity to participate in active AEFI surveillance and thus it is important that 
barriers to their participation are better understood and overcome. 
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